en

Sign up
Investments involve risks and are not suitable for all investors.

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

Home・Stock List・Cerevel Therapeutics Holdings Inc
Search

Cerevel Therapeutics Holdings Inc

Closed

Sector Healthcare

44.39 2.35

Neutral

Price update 25 Jul 2024, 19:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

43.37

Max

44.51

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+3.76 upside

Dividends

By Dow Jones

Next Earnings

31 Jul 2024

News Sentiment

By Acuity

50%

50%

129 / 369 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

42.6782 / 43.44 Support & Resistance

Cerevel Therapeutics Holdings Inc Chart

Related News

22 Dec 2023, 16:00 UTC

Acquisitions, Mergers, Takeovers

Trending: Bristol Myers to Buy Karuna Therapeutics for $14 Billion

DJ

Read

7 Dec 2023, 15:12 UTC

Acquisitions, Mergers, Takeovers

Trending: AbbVie to Buy Cerevel for $45 a Share

DJ

Read

6 Dec 2023, 21:55 UTC

Acquisitions, Mergers, Takeovers

AbbVie to Buy Cerevel Therapeutics for $8.7 Billion -- Update

DJ

Read

6 Dec 2023, 21:50 UTC

Acquisitions, Mergers, Takeovers

AbbVie to Buy Cerevel Therapeutics for $8.7 Billion

DJ

Read

6 Dec 2023, 21:44 UTC

Acquisitions, Mergers, Takeovers

AbbVie Close to $8 Billion Deal for Cerevel Therapeutics, Sources Say, Reuters Reports

DJ

Read

12 Feb 2024, 12:51 UTC

Acquisitions, Mergers, Takeovers

AbbVie's Stock Dips Premarket After It Lowers Q1 Guidance To Reflect Dilutive Impact Of ImmunoGen Deal Close -- MarketWatch

DJ

Read

8 Dec 2023, 16:14 UTC

Acquisitions, Mergers, Takeovers

Biotech Deals Are Heating Up. Why 2024 Could Be Even Hotter for M&A. -- Barrons.com

DJ

Read

8 Dec 2023, 12:00 UTC

Top News
Earnings
Acquisitions, Mergers, Takeovers

19 Billion in a Week: AbbVie Makes Two Big Bets -- Heard on the Street -- WSJ

DJ

Read

7 Dec 2023, 18:34 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Neuro-Drug Makers Looking Valuable After AbbVie-Cerevel Deal -- Market Talk

DJ

Read

7 Dec 2023, 18:05 UTC

Market Talk
Acquisitions, Mergers, Takeovers

AbbVie-Cerevel Deal Could Get Regulatory Scrutiny -- Market Talk

DJ

Read

7 Dec 2023, 13:23 UTC

Market Talk
Acquisitions, Mergers, Takeovers

AbbVie Betting on Cerevel Schizophrenia Candidate -- Market Talk

DJ

Read

7 Dec 2023, 12:48 UTC

Market Talk
Acquisitions, Mergers, Takeovers

AbbVie Dividend Secure Despite Deal-Making -- Market Talk

DJ

Read

7 Dec 2023, 10:33 UTC

Acquisitions, Mergers, Takeovers

AbbVie Makes Another Big Pharma Acquisition. How It's Putting Its Cash to Work. -- Barrons.com

DJ

Read

6 Dec 2023, 21:32 UTC

Acquisitions, Mergers, Takeovers

AbbVie: Emraclidine Has Potential to Transform the Standard of Care in Schizophrenia and Other Psychiatric Conditions >ABBV

DJ

Read

6 Dec 2023, 21:32 UTC

Acquisitions, Mergers, Takeovers

AbbVie: Cerevel's Clinical-Stage Pipeline Complements AbbVie's Current on-Market Portfolio and Emerging Neuroscience Pipeline >ABBV

DJ

Read

6 Dec 2023, 21:32 UTC

Acquisitions, Mergers, Takeovers

AbbVie: Transaction Valued at $45.00 Per Shr in Cash, for a Total Equity Value of Approximately $8.7B >ABBV

DJ

Read

6 Dec 2023, 21:32 UTC

Acquisitions, Mergers, Takeovers

AbbVie: Proposed Acquisition Adds Pipeline Focused on Best-in-Class Potential for Psychiatric and Neurological Disorders Where Significant Unmet Needs Remain >ABBV

DJ

Read

6 Dec 2023, 21:30 UTC

Acquisitions, Mergers, Takeovers

AbbVie To Acquire Cerevel Therapeutics In Transformative Transaction To Strengthen Neuroscience Pipeline >ABBV CERE

DJ

Read

6 Dec 2023, 21:29 UTC

Acquisitions, Mergers, Takeovers

AbbVie Close to $8B Deal for Cerevel Therapeutics, Sources Say, Reuters Reports

DJ

Read

Peer Comparison

Price change

Cerevel Therapeutics Holdings Inc Forecast

Price Target

By TipRanks

3.76% upside

12 Months Forecast

Average 45 USD  3.76%

High 45 USD

Low 45 USD

Based on 1 Wall Street analysts offering 12 month price targets forCerevel Therapeutics Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

1 ratings

0

Buy

1

Hold

0

Sell

Based on 1 analysts giving stock ratings to Cerevel Therapeutics Holdings Inc - Dist in the past 3 months.

Technical Score

By Trading Central

42.6782 / 43.44Support & Resistance

Short Term

Strong Bullish Evidence

Recent bullish events outweigh bearish events.

Intermediate Term

Bullish Evidence

Recent bullish events outweigh bearish events.

Long Term

No Evidence

There are no events.

Sentiment

By Acuity

129 / 369 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Above average

Other stocks from the sector

LLY

Eli Lilly and Co.

802.55

↓-2.25%

UNH

UnitedHealth Group Inc

569.62

↑ +1.64%

NVO

Novo Nordisk A-S

126.83

↓-0.63%

JNJ

Johnson and Johnson

160.55

↑ +0.48%

MRK

Merck & Co Inc.

125.13

↓-0.6%